Evalify

?? The Vaccine War You Didn't Hear About While the world focused on fighting COVID-19, a legal battle was brewing behind the scenes. In 2022, CureVac sued BioNTech, claiming its mRNA patents were used without permission in the Comirnaty vaccine. This case is a stark reminder that patents can be as critical as the science itself—especially in fast-moving, high-stakes industries like biotech. Learn from other real-world cases that cost companies millions. ?? Download our E-book: 13 IP Horror Stories Every Investor Must Know ?? https://lnkd.in/gtcfrBXw #IPStrategy #BiotechInvesting #PatentLitigation #Evalify

?? Investors, how much does IP due diligence factor into your decision-making? With patent risks capable of making or breaking a startup, should IP be a top priority—or just part of the process? - A major factor ? - A moderate factor ?? - A minor factor ?? - Not a factor ? Vote below and share your thoughts! ?? #Evalify #IPDueDiligence #StartupInvesting #RiskManagement

?? Investors, how much does IP due diligence factor into your decision-making? With patent risks capable of making or breaking a startup, should IP be a top priority—or just part of the process? Vote below and share your thoughts! ?? #Evalify #IPDueDiligence #StartupInvesting #RiskManagement

$120 Million Down the Drain: When Patents Can't Save a Flawed Product Remember Juicero? The Silicon Valley darling that convinced smart investors to pour $120 million into a juice press that... wasn't actually needed? This cautionary tale remains one of tech's most painful examples of how patents alone don't guarantee success. Despite an impressive patent portfolio protecting their high-tech juicing technology, investors discovered an embarrassing truth: you could squeeze those proprietary juice packs by hand and get the same result. The company collapsed in 2017, but the lesson remains incredibly relevant today. Learn from real-world cases that cost companies millions. ?? Download our E-book: 13 IP Horror Stories Every Investor Must Know ?? https://lnkd.in/gtcfrBXw #IPStrategy #StartupInvesting #RiskManagement #Evalify

?? How a $1 Billion Patent Victory Against Google Disappeared Overnight ?? Imagine winning a billion-dollar lawsuit—only to have it wiped out in an instant. That’s exactly what happened in the Vringo vs. Google patent battle. This case is a brutal reminder: betting on litigation is risky, and patent battles are never a guaranteed payday. ??Read the full article to learn more ?? #IPStrategy #StartupLessons #PatentWars #Evalify

?? Investors: Are You Overlooking This Critical Step? Would you buy a property without checking the title? Investing in a startup without a Preliminary Freedom to Operate (FTO) assessment is just as risky. ?? Unchecked patent risks can lead to: ?? Costly legal battles ?? Lost revenue streams ?? Massive valuation hits An FTO isn’t just legal red tape — it’s a competitive score that reveals a startup’s true market position. ?? Don’t let unseen risks derail your investments. Read the full article to learn why Evalify's FTO should be part of your due diligence strategy. ?? https://lnkd.in/g6DydBuY #StartupInvesting #VentureCapital #IPStrategy #RiskManagement #Evalify

These are the top 10 reasons why #startups fail, according to CB Insights. The most common reasons include running out of cash (38%), lack of market need (35%), and getting outcompeted (20%). Very close to the podium, and almost 1 out of 5 startups is "#legal challenges" with 18%. It's part of why we have built Evalify. Understanding these failure points can help founders build more resilient businesses. #IP #IPStrategy #Patents #PatentStrategy #StartupInvesting #Innovation #StartupSuccess #RiskManagement #VentureCapital

?? The Patent That Changed E-Commerce Amazon’s 1-Click patent wasn’t just about faster checkouts—it ignited a major debate on software patents. ?? Key Lessons for Startups & Investors: ? Even simple innovations can hold massive strategic value ? Aggressive patent enforcement can spark controversy ? Understanding evolving patent standards is crucial Want to avoid costly IP mistakes? Learn from real-world cases that cost companies millions. ?? Download our E-book: 13 IP Horror Stories Every Investor Must Know ?? https://lnkd.in/gtcfrBXw #PatentStrategy #StartupInvesting #Innovation #Ecommerce #Amazon #Evalify

??? IP Strategy Isn’t Optional—It’s Essential In today’s fast-moving startup landscape, ignoring your IP risks isn’t just careless—it’s dangerous. ?? Evalify turns patent data into a tactical advantage, helping startups and investors: ? Avoid costly legal traps ? Plan smarter growth strategies ? Enter the market with confidence Don't gamble on innovation without protection. Learn how Evalify helps you build smarter, safer investments. ?? Read the full article to see why IP strategy is a must-have for serious founders and investors. ?? https://lnkd.in/g6DydBuY #StartupSuccess #IPStrategy #RiskManagement #VentureCapital #Evalify

?? The $2.54B Patent Battle Every Investor Should Know Idenix’s record-breaking $2.54 billion victory over Gilead wasn’t just a win—it was a warning. ?? In biotech and high-stakes innovation, one patent dispute can cripple a company’s future. ?? Don’t let IP risks blindside you. Learn from real-world cases that cost companies millions. ?? Download our E-book: 13 IP Horror Stories Every Investor Must Know ?? https://lnkd.in/gtcfrBXw #IPStrategy #StartupInvesting #PatentLitigation #RiskManagement #Evalify